171 related articles for article (PubMed ID: 3840268)
21. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Garland J; Buck R; Weinberg M
Pediatrics; 1994 Nov; 94(5):719-23. PubMed ID: 7936902
[TBL] [Abstract][Full Text] [Related]
22. [Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].
Speer CP; Harms K; Herting E; Müller F; Schröter W; Teichmann AT; Neumann N; Curstedt T; Robertson B
Geburtshilfe Frauenheilkd; 1990 May; 50(5):359-64. PubMed ID: 2197165
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant].
Speer CP; Harms K; Müller U; Schröter W; Curstedt T; Robertson B
Monatsschr Kinderheilkd; 1988 Feb; 136(2):65-70. PubMed ID: 3130571
[TBL] [Abstract][Full Text] [Related]
24. Exogenous lung surfactant: effect on radiographic appearance in premature infants.
Wood BP; Sinkin RA; Kendig JW; Notter RH; Shapiro DL
Radiology; 1987 Oct; 165(1):11-3. PubMed ID: 3306780
[TBL] [Abstract][Full Text] [Related]
25. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
26. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
Robertson B
Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
[TBL] [Abstract][Full Text] [Related]
27. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials.
Kendig JW; Notter RH; Cox C; Aschner JL; Benn S; Bernstein RM; Hendricks-Munoz K; Maniscalco WM; Metlay LA; Phelps DL
Pediatrics; 1988 Nov; 82(5):756-62. PubMed ID: 3054783
[TBL] [Abstract][Full Text] [Related]
28. Respiratory distress syndrome in Curaçao. Conventional versus surfactant treatment.
Verhagen AA; van der Meulen GN; Wiersma HE; Keli SO; Angelista IR; Muskiet FD; van Meer H
West Indian Med J; 2002 Jun; 51(2):68-73. PubMed ID: 12232944
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.
Seppänen M; Kääpä P; Kero P
Am J Perinatol; 1994 Nov; 11(6):382-5. PubMed ID: 7857426
[TBL] [Abstract][Full Text] [Related]
30. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?
Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246
[TBL] [Abstract][Full Text] [Related]
31. Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome.
Bunt JE; Carnielli VP; Janssen DJ; Wattimena JL; Hop WC; Sauer PJ; Zimmermann LJ
Crit Care Med; 2000 Oct; 28(10):3383-8. PubMed ID: 11057790
[TBL] [Abstract][Full Text] [Related]
32. Comparison of clinical efficacy of Newfactan versus Surfacten for the treatment of respiratory distress syndrome in the newborn infants.
Choi CW; Hwang JH; Yoo EJ; Kim KA; Koh SY; Lee YK; Shim JW; Lee EK; Chang W; Kim SS; Chang YS; Park WS; Shin SM
J Korean Med Sci; 2005 Aug; 20(4):591-7. PubMed ID: 16100449
[TBL] [Abstract][Full Text] [Related]
33. Improving the results of ligation of patent ductus arteriosus in small preterm infants.
Nelson RJ; Thibeault DW; Emmanouilides GC; Lippmann M
J Thorac Cardiovasc Surg; 1976 Feb; 71(2):169-78. PubMed ID: 1246141
[TBL] [Abstract][Full Text] [Related]
34. Radiographic findings associated with surfactant treatment.
Soll RF; Horbar JD; Griscom NT; Barth RA; Lucey JF; Taeusch HW
Am J Perinatol; 1991 Mar; 8(2):114-8. PubMed ID: 2006936
[TBL] [Abstract][Full Text] [Related]
35. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD
West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907
[TBL] [Abstract][Full Text] [Related]
36. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
37. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy.
Heldt GP; Pesonen E; Merritt TA; Elias W; Sahn DJ
Pediatr Res; 1989 Mar; 25(3):305-10. PubMed ID: 2649864
[TBL] [Abstract][Full Text] [Related]
38. Prevention of symptomatic patent ductus arteriosus with ethamsylate in babies treated with exogenous surfactant.
Amato M; Hüppi P; Markus D
J Perinatol; 1993; 13(1):2-7. PubMed ID: 8445442
[TBL] [Abstract][Full Text] [Related]
39. Increased shunt through the patent ductus arteriosus after surfactant replacement therapy.
Clyman RI; Jobe A; Heymann M; Ikegami M; Roman C; Payne B; Mauray F
J Pediatr; 1982 Jan; 100(1):101-7. PubMed ID: 6948942
[TBL] [Abstract][Full Text] [Related]
40. Patent ductus arteriosus ligation and respiratory distress syndrome in premature infants.
Clarke DR; Paton BC; Way GL; Stewart JR
Ann Thorac Surg; 1976 Aug; 22(2):138-45. PubMed ID: 973762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
